Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Free Report) reached a new 52-week low on Monday . The stock traded as low as $79.32 and last traded at $80.57, with a volume of 3878634 shares traded. The stock had previously closed at $84.40.
SPDR S&P Biotech ETF Trading Down 5.0 %
The stock has a market capitalization of $5.20 billion, a P/E ratio of 11.47 and a beta of 0.99. The company has a fifty day simple moving average of $89.40 and a two-hundred day simple moving average of $93.91.
SPDR S&P Biotech ETF Cuts Dividend
The company also recently declared a dividend, which was paid on Wednesday, March 26th. Investors of record on Monday, March 24th were given a $0.0053 dividend. The ex-dividend date was Monday, March 24th.
Institutional Trading of SPDR S&P Biotech ETF
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- What is the Euro STOXX 50 Index?
- 3 Stocks Near 52-Week Lows With Strong Rebound Potential
- What Are Dividend Champions? How to Invest in the Champions
- Casey’s General Stores Insider Buys Shares of This Must-Own Stock
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- U.S. Steel and Nippon Merger: Should Investors Bet on It?
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.